The U.S. Department of Energy this month issued a request forproposal for project definition studies of a National BiomedicalTracer Facility (NBTF). The facility would create a domestic sourcefor radioisotopes produced by linear accelerators (SCAN
The U.S. Department of Energy this month issued a request forproposal for project definition studies of a National BiomedicalTracer Facility (NBTF). The facility would create a domestic sourcefor radioisotopes produced by linear accelerators (SCAN 4/21/93).
Nuclear medicine advocates claim that the NBTF is needed becauseof a shortage of domestically-produced radioisotopes. They successfullylobbied Congress to order the DOE to appropriate $2 million tofund the project definition studies, which would examine variousfactors involved in building the NBTF, such as cost, locationand construction schedule. The $2 million appropriation is likelyto be approved shortly.
The DOE is expected to approve five applications for fundingproject definition studies, with federal funding amounting to$300,000 per study. Applications must be received by Feb. 1, 1994.
The request for proposal was published in the Oct. 14 issueof the Federal Register.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.